Invest Securities maintains its Buy rating on Dassault Systèmes shares, with a price target raised from 48 to 50 euros.

The analyst believes that yesterday's decline of over 4% reflects a loss of credibility on the part of the CFO post Q4 2023, after he underestimated the scale and length of the Medidata slowdown.

If Medidata's new roadmap was confirmed yesterday (stable sales in 2024, before >+10% growth in 2025), investors will not be satisfied with guidance, but will wait to see what actually happens", points out Invest.

The broker also sees the current price as an opportunity, 'even if the revaluation could wait until late 2024-early 2025, the time needed to reassure investors about Medidata'.


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.